1. Academic Validation
  2. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

  • Adv Exp Med Biol. 1997:407:73-8.
C K Lau 1 W C Black M Belley C Chan S Charleson D Denis J Y Gauthier R Gordon D Guay P Hamel S Kargman Y Leblanc J Mancini M Ouellet D Percival P Prasit P Roy K Skorey P Tagari P Vickers E Wong
Affiliations

Affiliation

  • 1 Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Québec, Canada.
PMID: 9321934
Figures
Products